Drug that holds back return of ovarian cancer gets UK licence

Professor Jonathan Ledermann (UCL Cancer Institute) comments on the launch of a milestone drug in the UK to delay the progression of ovarian cancer. Read: Guardian, More: Independent, Daily Mail